Compare SHW & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHW | SYK |
|---|---|---|
| Founded | 1866 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.7B | 127.0B |
| IPO Year | 1994 | 1994 |
| Metric | SHW | SYK |
|---|---|---|
| Price | $334.37 | $348.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $380.55 | ★ $417.50 |
| AVG Volume (30 Days) | 1.6M | ★ 1.9M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | 0.96% | ★ 1.01% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | ★ 10.26 | 8.40 |
| Revenue | $17,900,800,000.00 | ★ $25,116,000,000.00 |
| Revenue This Year | $5.34 | $9.85 |
| Revenue Next Year | $4.68 | $8.36 |
| P/E Ratio | ★ $32.56 | $41.34 |
| Revenue Growth | 2.09 | ★ 11.16 |
| 52 Week Low | $301.58 | $319.32 |
| 52 Week High | $379.65 | $404.87 |
| Indicator | SHW | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 54.18 |
| Support Level | $327.97 | $328.23 |
| Resistance Level | $335.30 | $375.26 |
| Average True Range (ATR) | 7.59 | 7.69 |
| MACD | 3.40 | 3.05 |
| Stochastic Oscillator | 82.58 | 80.79 |
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 4,800 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.